2015 results, reiterating an expected cash runway into 2017 and confirming timelines for releasing clinical data for key pipeline projects in H116 are on track. Phase II data in renal cancer are expected by end June for its highprofile CRLX101, which uses its nanoparticle drug delivery system
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Approaching release of Phase II renal data
- Published:
16 Mar 2016 -
Author:
Katherine Genis -
Pages:
3
2015 results, reiterating an expected cash runway into 2017 and confirming timelines for releasing clinical data for key pipeline projects in H116 are on track. Phase II data in renal cancer are expected by end June for its highprofile CRLX101, which uses its nanoparticle drug delivery system